Improving Cancer Care Via Patient Empowerment And System Transformation
12/26/2011
Physicians can use medical records to track the quality of cancer care and determine whether their patients are receiving the right treatments at the right time. Yet the patient is the only one who ultimately can evaluate the quality of his or her experience while receiving treatment...
Roche's Avastin Receives EU Approval For Ovarian Cancer
12/25/2011
Roche announced today that its product known as Avastin (bevacizumab) has been approved by the European Union for treatment of ovarian cancer. When used in combination with standard chemotherapy (carboplatin and paclitaxel) it will be part of a front-line (first-line following surgery) regime. Hal Barron M.D...
Acid Reflux 50% More Common Than Ten Years Ago
12/25/2011
A long-term Norwegian study reveals the number of people who experience acid reflux at least once a week has gone up by nearly 50% in the last 10 years, with women appearing to be more susceptible to the condition than men...
Visualization Of DNA Synthesis In Vivo
12/25/2011
Interactions of biological macromolecules are the central bases of living systems. Biological macromolecules are synthesized in living cells by linking many small molecules together. Naturally occurring macromolecules include genetic materials (DNA) and proteins...
Lifestyle And Environmental Factors Associated With Cancer Risk
12/25/2011
It has been well established that certain lifestyle habits relate to the risk of certain cancers (e.g., smoking and lung cancer). In a well-done analysis, the authors estimate the proportion of cancer in the population associated with a variety of lifestyle and environmental factors. They find that smoking has, by far, the largest effect on the risk of cancer, with 19...
Roche's Avastin Receives EU Approval For Ovarian Cancer
12/25/2011
Roche announced today that its product known as Avastin (bevacizumab) has been approved by the European Union for treatment of ovarian cancer. When used in combination with standard chemotherapy (carboplatin and paclitaxel) it will be part of a front-line (first-line following surgery) regime. Hal Barron M.D...
Roche's Avastin Receives EU Approval For Ovarian Cancer
12/24/2011
Roche announced today that its product known as Avastin (bevacizumab) has been approved by the European Union for treatment of ovarian cancer. When used in combination with standard chemotherapy (carboplatin and paclitaxel) it will be part of a front-line (first-line following surgery) regime. Hal Barron M.D...
Researchers Present Findings From Kentucky Breast Cancer Patients With Disease Relapse
12/24/2011
The University of Kentucky Markey Cancer Center breast oncologist Dr. Suleiman Massarweh and his research team presented findings from their studies on relapse of breast cancer at the San Antonio Breast Cancer Symposium this month. The two studies aimed to characterize further risk factors for presentation with metastatic disease or risk of early metastatic relapse after initial therapy...
HPV Vaccine Does Not Alter Sexual Behavior
12/24/2011
According to a national study by The Centers for Disease Control & Prevention published in the American Journal of Preventive Medicine, contrary to some people's belief, young women receiving recommended vaccinations for the prevention of human papillomavirus (HPV) infection and related cancers do not engage in more sexually risky behavior. Nicole C. Liddon, Ph.D...
A New Sensor To Detect Lung Cancer From Exhaled Breath
12/24/2011
Tecnalia, through the Interreg project Medisen, is contributing to develop biosensors capable of detecting the presence of tumour markers of lung cancer in exhaled breath...